News Releases

This information is part of the archives and is no longer current and may no longer be accurate.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Nov 13, 2013DURECT Announces Closing of Public Offering of Common StockPrinter Friendly Version
Nov 08, 2013DURECT Announces Pricing of Public Offering of Common StockPrinter Friendly Version
Nov 07, 2013DURECT Announces Proposed Public Offering of Common StockPrinter Friendly Version
Nov 04, 2013DURECT Corporation Announces Third Quarter 2013 Financial Results and Update of ProgramsPrinter Friendly Version
Oct 28, 2013DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference CallPrinter Friendly Version
Oct 22, 2013Pfizer Proceeding with REMOXY® DevelopmentPrinter Friendly Version
Sep 27, 2013DURECT Announces Changes to its Board of DirectorsPrinter Friendly Version
Sep 03, 2013DURECT to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
Aug 05, 2013DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of ProgramsPrinter Friendly Version
Aug 01, 2013DURECT Announces Selection with Orient PHARMA of Lead Formulation for ORADUR®-MethylphenidatePrinter Friendly Version
Jul 26, 2013DURECT Corporation Invites You to Join its Second Quarter 2013 Earnings Conference CallPrinter Friendly Version
Jun 20, 2013DURECT Announces FDA Acceptance of New Drug Application (NDA) Submission for POSIDUR® (SABER®-Bupivacaine)Printer Friendly Version
May 10, 2013DURECT Announces Update on Remoxy®Printer Friendly Version
May 02, 2013DURECT Corporation Announces First Quarter 2013 Financial Results and Update of ProgramsPrinter Friendly Version
Apr 24, 2013DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference CallPrinter Friendly Version
Apr 16, 2013DURECT Announces Submission of New Drug Application for POSIDUR™ (SABER®-Bupivacaine)Printer Friendly Version
Feb 28, 2013DURECT Corporation Announces Fourth Quarter 2012 Financial Results and Update of ProgramsPrinter Friendly Version
Feb 22, 2013DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference CallPrinter Friendly Version
Feb 05, 2013DURECT to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
Jan 03, 2013DURECT Announces Positive Results from Relday™ Phase 1 Clinical TrialPrinter Friendly Version